Dr. Timothy A. Leichliter, MD

Dr. Leichliter practices at AHN Neurology in Pittsburgh, Pennsylvania.

Dr. Leichliter's NPI, 1649568379, was assigned on July 15, 2011. Dr. Leichliter graduated from Lewis Katz School of Medicine in 2009. Dr. Leichliter holds Pennsylvania license MD448076.

Dr. Leichliter's primary practice is AHN Neurology, at 420 E North Ave, Pittsburgh, PA 15212 in Allegheny County. The practice phone is (412) 330-5861.

Dr. Leichliter's primary practice is AHN Neurology in Pittsburgh, Pennsylvania. Dr. Leichliter is also affiliated with Allegheny General Hospital. The medical group on file is AHN Primary Care - Family Med Associates at H+W Pavilion Bethel Park. Dmand AI also links Dr. Leichliter to 4 more hospitals, 4 medical groups, 3 group practices and clinics, 2 home health agencies and 1 therapy and rehab clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Leichliter practices, 11 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Leichliter's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Leichliter is board certified in neurology by the American Board of Psychiatry and Neurology. Dr. Leichliter is licensed in Pennsylvania.

Dmand AI lists acute mini-stroke (TIA), alzheimer's disease, encephalopathy, epilepsy, essential tremor, head injury, hereditary polyneuropathy and lower back pain among the conditions Dr. Leichliter treats.

CMS data shows 6,376 Medicare services from Dr. Leichliter across 11 procedure codes in 2024, for 560 Medicare patients. Medicare paid $98,836 for them.

CMS counts 560 Medicare patients who saw Dr. Leichliter in 2024. The largest group is 65 to 74, with 295 patients. 75% of them have high cholesterol, and 73% have high blood pressure. 6% are also on Medicaid. Their average risk score is 1.64, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Leichliter's median patient age at 74, with 46% women.

In 2024, Dr. Leichliter wrote 11,610 Medicare Part D claims for 1,389 patients. 86% of them were for generic drugs. CMS names the drug for 11,237 of them, across 85 drugs with 11 or more claims each, at $4,647,061 in total drug cost. In 2023, CMS named 8,633 claims across 76 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Leichliter for performance year 2024, reported through an alternative payment model (APM). Dr. Leichliter accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Leichliter as offering telehealth.

Dmand AI links 4 papers to Dr. Leichliter, published from 2016 to 2021. Dr. Leichliter's most frequent co-authors are Susan M. Baser, MD, Mary Catherine Flaherty, DO and Thomas F. Scott, MD.

Dmand AI links Dr. Leichliter to 1 clinical trial. Conditions studied include Parkinson Disease and Parkinsonian Disorders.

CMS Open Payments shows 222 general payments to Dr. Leichliter from 22 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 70% of the total. Neurocrine BioSciences, Inc. paid the most, $66,581.

Dr. Leichliter graduated from Lewis Katz School of Medicine in 2009. Dr. Leichliter is a member of AAN and MDS.

Dr. Leichliter is in network with 19 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.